can tirzepatide cause low blood pressure and reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial GLP-1 drugs tied to elevated

Once the patient has started using the injection pen, it can be kept at room temperature, not exceeding 30 degrees Celsius (86 degrees Fahrenheit), for a limited period as per the manufacturers guidelines, and should be discarded after the use or expiry date, whichever comes first

Injecting into muscle changes the absorption rate and can cause more pain and bruising

Injectables that are potentially less frequent than weekly

These can look like swelling in the face or strong belly pain, especially in your upper stomach

The following sources give you the unfiltered picture - clinical evidence, regulatory context, and safety data straight from the organizations that publish it: FDA.gov - official FDA communications on compounded semaglutide, tirzepatide, and the 503B Bulks List proposal (April 30, 2026)